Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

INTRODUCTION: One of the concepts of theranostics in nuclear medicine is peptide receptor radionuclide therapy (PRRT), whereby labeled somatostatin analogs are used for imaging and treating inoperable or disseminated neuroendocrine tumors (NET). AIM: The aim of the study was to determine the therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunikowska, Jolanta, Zemczak, Anna, Kołodziej, Maciej, Gut, Paweł, Łoń, Izabela, Pawlak, Dariusz, Mikołajczak, Renata, Kamiński, Grzegorz, Ruchała, Marek, Kos-Kudła, Beata, Królicki, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075861/
https://www.ncbi.nlm.nih.gov/pubmed/31980909
http://dx.doi.org/10.1007/s00259-020-04690-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075861/
https://www.ncbi.nlm.nih.gov/pubmed/31980909
http://dx.doi.org/10.1007/s00259-020-04690-5

Ejemplares similares